Compare Mitra Energi Persada Tbk. (KOPI) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mitra Energi Persada Tbk. vs Merck Tbk. — how do they compare? Mitra Energi Persada Tbk. trades at Rp199 (market cap 145.03B, 7.79M 24h volume), while Merck Tbk. trades at Rp3,900 (market cap 1.76T, 63K 24h volume). The key difference: Merck Tbk. is far larger — about 12.1× Mitra Energi Persada Tbk.'s market cap, and Mitra Energi Persada Tbk. is more actively traded (7.79M versus 63K). Which is the better fit depends on your goals.
| KOPI | MERK | |
|---|---|---|
Market Cap | 145.03B | 1.76T |
Volume | 7.79M | 63K |
Lot | 77.94K | 630 |
Turnover | 1.71B | 243.97M |
Average Price | 219.42 | 3,872.46 |
Value | 1.71B | 243.97M |
Indicative Equilibrium Price | 199 | 3,900 |
Indicative Equilibrium Volume | 693 | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mitra Energi Persada Tbk.
PT Mitra Energi Persada Tbk (formerly PT Korpora Persada Investama, Tbk) (the "Company") a public listed company registered in Indonesia Stock Exchange) was first established under the name of Adwitiya Alembana an Advertising Company, drawn up before notary Kartini Muljadi, SH No. 200 dated 24 February 1981. The Company is domiciled in Jakarta and started operations since 1982.
Read more on KOPI →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
